Patients treated with on dupilumab showed significant improvement in sustained BP remission compared with those on placebo.
COVID-19 has little impact on patients with dermatological immune-mediated inflammatory diseases, with effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback